We are live on
!
Find out more
CAM
Cypress Asset Management Portfolio holdings
AUM
$455M
1-Year Est. Return
26.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.57%
1 Year Est. Return
+26.87%
3 Year Est. Return
+113.59%
5 Year Est. Return
+132.49%
10 Year Est. Return
+426.19%
AUM
$535M
AUM Growth
-$8.49M
(-1.6%)
Cap. Flow
-$7.42M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
219
New
20
Increased
45
Reduced
105
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.26M |
| 2 |
Kimberly-Clark
KMB
|
+$3.61M |
| 3 |
GSK
GSK
|
+$3.47M |
| 4 |
General Dynamics
GD
|
+$3.43M |
| 5 |
Lockheed Martin
LMT
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$6.53M |
| 2 |
Targa Resources
TRGP
|
+$4.75M |
| 3 |
SLB Ltd
SLB
|
+$4.19M |
| 4 |
Toronto Dominion Bank
TD
|
+$1.8M |
| 5 |
Chevron
CVX
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 21.06% |
| 2 | Industrials | 15.19% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Staples | 13.77% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Colgate-Palmolive
CL
$73.3B
| $3.61M | 0.68% |
52,121
-2,550
| -5% | -$176K |
|
|
MWE
52
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $3.59M | 0.67% |
54,257
-1,472
| -3% | -$90.4K |
|
53
Analog Devices
ADI
$179B
| $3.46M | 0.65% |
54,890
-900
| -2% | -$51.1K |
|
54
McDonald's
MCD
$191B
| $3.46M | 0.65% |
35,468
-8,587
| -19% | -$815K |
|
|
55
General Dynamics
GD
$103B
| $3.4M | 0.63% |
+25,010
| New | +$3.43M |
|
|
DD
56
DELISTED
Du Pont De Nemours E I
DD
| $3.29M | 0.62% |
48,484
-1,165
| -2% | -$83.1K |
|
57
Canadian National Railway
CNI
$76.9B
| $3.27M | 0.61% |
48,962
-1,600
| -3% | -$109K |
|
58
Mondelez International
MDLZ
$80.5B
| $3.12M | 0.58% |
86,317
-4,350
| -5% | -$157K |
|
59
Deere & Co
DE
$162B
| $3.04M | 0.57% |
34,659
-1,932
| -5% | -$171K |
|
60
Norfolk Southern
NSC
$75B
| $2.98M | 0.56% |
28,928
-1,565
| -5% | -$167K |
|
|
XIFR
61
XPLR Infrastructure LP
XIFR
$1.12B
| $2.68M | 0.5% |
+61,250
| New | +$2.44M |
|
62
Sanofi
SNY
$103B
| $2.61M | 0.49% |
52,855
+11,830
| +29% | +$566K |
|
|
MPT
63
Medical Properties Trust
MPT
$2.81B
| $2.55M | 0.48% |
172,900
-3,950
| -2% | -$58.7K |
|
64
Costco
COST
$423B
| $2.36M | 0.44% |
15,600
+11,100
| +247% | +$1.63M |
|
|
ETP
65
DELISTED
Energy Transfer Partners, L.P.
ETP
| $2.32M | 0.43% |
56,050
-1,900
| -3% | -$80.5K |
|
|
WBA
66
DELISTED
Walgreens Boots Alliance
WBA
| $2.31M | 0.43% |
27,327
+18,225
| +200% | +$1.45M |
|
67
Nike
NKE
$62.7B
| $2.26M | 0.42% |
45,020
-2,600
| -5% | -$124K |
|
68
Welltower
WELL
$170B
| $2.25M | 0.42% |
29,030
+5,525
| +24% | +$435K |
|
|
UN
69
DELISTED
Unilever NV New York Registry Shares
UN
| $2.23M | 0.42% |
53,460
+12,745
| +31% | +$535K |
|
70
Novartis
NVS
$301B
| $2.21M | 0.41% |
25,062
-84
| -0.3% | -$7.45K |
|
|
TWX
71
DELISTED
Time Warner Inc
TWX
| $2.13M | 0.4% |
25,255
+1,725
| +7% | +$143K |
|
72
Lowe's Companies
LOW
$118B
| $2.11M | 0.4% |
28,423
-555
| -2% | -$39.8K |
|
73
American Express
AXP
$228B
| $2.11M | 0.39% |
26,955
+6,855
| +34% | +$570K |
|
74
ConocoPhillips
COP
$145B
| $2.08M | 0.39% |
33,449
+2,123
| +7% | +$137K |
|
|
RTN
75
DELISTED
Raytheon Company
RTN
| $1.99M | 0.37% |
18,255
+10,380
| +132% | +$1.12M |
|
Similar funds
VW
MG
CIP
STS
KK
JHCM
VFPW
HFA
Cypress Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Cypress Asset Management held 219 positions worth $535M, down 1.6% from $543M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cypress Asset Management's Q1 2015 filing shows 20 new, 45 increased, 105 reduced and 19 closed positions. Its largest new stake was AstraZeneca: 61,310 shares worth $4.2M. The largest sale was Philip Morris, an estimated $6.53M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.
- Cypress Asset Management's largest Q1 2015 buy was AstraZeneca: 61,310 shares worth $4.2M.
- Cypress Asset Management added most to Kimberly-Clark in Q1 2015, an estimated $3.61M increase.
- Cypress Asset Management's biggest Q1 2015 reduction was Philip Morris, cutting an estimated $6.53M.
- Cypress Asset Management fully exited Targa Resources in Q1 2015, selling an estimated $4.75M.
- Cypress Asset Management's ten largest holdings make up 24% of its $535M portfolio in Q1 2015.
- Cypress Asset Management opened 20 new positions and closed 19 in Q1 2015.
- Cypress Asset Management's portfolio value fell 1.6% quarter-over-quarter to $535M.
Based on Cypress Asset Management's 13F filing for Q1 2015, filed 11 May 2015.